You searched for Curaleaf | CannIntelligence

‘Revolutionary’ US cannabis rescheduling set to increase companies’ profitability

Written by Tiziana Cauli | 9th May 2024

The reclassification of cannabis to a less restrictive schedule of the US Controlled Substances Act will have crucial implications for the industry, especially as far as taxation is concerned, experts...

Struggling industry blames FDA as Canadian companies leave US market

Written by CannIntelligence | 7th September 2023

Another major Canadian cannabinoid company is leaving the US market amid concerns over the regulatory environment some say the US Food and Drug Administration has caused ...

Cannabis companies shed US assets to focus on more lucrative markets

Written by Lorraine Mullaney | 27th July 2023

Major cannabis firms are streamlining their North American operations and reallocating resources toward markets with what they see as more long-term growth potential ...

Curaleaf denies undercover cash links with sanctioned Russian billionaire

Written by Lorraine Mullaney | 8th February 2023

US cannabis firm Curaleaf has denied having any secret financial ties to the Russian billionaire Roman Abramovich, who has been sanctioned in the UK and EU since the outbreak of...

How did we do? CannIntelligence’s 2022 predictions measured against events

Written by Freddie Dawson | 18th January 2023

CannIntelligence predicted that 2022 would be the year of intoxicating hemp-derived cannabinoids (IHDCs) and that has proven to be the case. But’s not been plain sailing for cannabis or CBD ...

Fresh regulation attracts international medical cannabis business to Poland

Written by Lorraine Mullaney | 27th September 2022

International cannabis firms are moving in on the market for medicinal cannabis in Poland in the wake of recent regulatory change in the country ...

Pennsylvania banking bill welcomed, but it's federal legislation they all want

Written by CannIntelligence | 17th August 2022

A new state law will help shield financial companies in Pennsylvania from prosecution over transactions with legal cannabis companies. But industry leaders say more protection is needed after a federal...

Another sign of mainstream acceptance as Amazon gets on board with CBD in US

Written by Freddie Dawson | 21st March 2022

Interest from major players in traditional retail channels continues to grow ...

CannIntelligence regulatory news in brief, 8th-14th January 2022

Written by CannIntelligence | 14th January 2022

This week's regulatory news in brief includes updates from the Germany, Italy, Malta, Portugal, UK, Canada, US, Brazil, Chile Costa Rica and India ...

CBD-Intel's crystal ball reveals possible intoxicating prospects for the year ahead

Written by Freddie Dawson | 29th December 2021

“Intoxicating” will be the word to watch for and THC will be the main driver for developments in 2022, CBD-Intel predicts ...

Cannabis companies go on acquisition spree for US stores and tech companies

Written by Lorraine Mullaney | 15th December 2021

Cannabis firms continued to expand their footprint through to the end of 2021, with the lucrative US market being the strategic focus of many acquisitions, covering retail chains and tech...

Multi-million, multi-state M&A deals as cannabis dispensaries spread across US

Written by Lorraine Mullaney | 17th November 2021

As the market for medical cannabis goes on growing, dispensaries continue to drive merger and acquisition activity in the US as multi-state operators invest millions of dollars in expanding their...

Cannabis dispensaries tempt investors into multimillion US acquisitions

Written by Lorraine Mullaney | 21st October 2021

US cannabis dispensaries are attracting significant interest from investors and several multi-million dollar deals have been agreed as operators expand their footprint into new states ...

CBD-Intel regulatory news in brief, 25th September-1st October

Written by CannIntelligence | 1st October 2021

This week's regulatory news in brief includes updates from Czech Republic, Germany, Ireland, Spain, Portugal, the US, Ecuador, Malaysia and Thailand ...

Italian company gains EU validation for synthetic CBD novel food application

Written by Freddie Dawson | 8th July 2021

The European Commission (EC) has validated a novel food application submitted by the Italian company Farmabios for a synthetic CBD. This is the first step to gaining novel food authorisation...

Jersey well placed to become Europe’s major growing hub for medical cannabis

Written by Lorraine Mullaney | 20th April 2021

Jersey could become “a cannabis hub for Europe” after Northern Leaf successfully completed a second round of funding that will enable it to complete its pharmaceutical cannabis cultivation facility on...

US and Australian cannabis companies see great profit potential in Europe

Written by Lorraine Mullaney | 2nd April 2021

There are profits to be made from selling cannabis in Europe, according to US company Curaleaf after it signed an agreement to acquire Europe’s largest vertically integrated independent cannabis company...

Tilray set on becoming the 'weed giant of the world' with Aphria merger

Written by Lorraine Mullaney | 29th December 2020

Canadian cannabis firms Aphria and Tilray have announced a merger that will create “the world’s largest weed company”, operating under the Tilray name ...

The trouble with GMP – and why EU producers are at a disadvantage

Written by CBD-Intel | 30th April 2020

GMP certification means little and European CBD producers are being held back by rules limiting varieties that can be grown, new analysis from CBD-Intel reveals. Our report also explains how...

Curaleaf takes action on FDA complaint over health claims

Written by Freddie Dawson | 5th September 2019

Curaleaf, a US-based vendor of CBD products with a presence in 12 states, has responded to warnings made by the FDA about its marketing of CBD products ...

CBD-Intel business news in brief, 29th July-2nd August 2019

Written by CannIntelligence | 5th August 2019

US food and pharmacy chain Kroger has increased its range of CBD products with deals to distribute CV Sciences, Veritas Farms and Charlotte’s Web products in 1350 stores across 22...

Curaleaf in hot water with FDA over ‘improper health claims’

Written by CannIntelligence | 25th July 2019

The US FDA has issued a warning to Curaleaf, which it says is selling CBD products with improper claims to treat diseases like cancer, withdrawal from opioids, pain, and anxiety...

CBD-Intel regulatory news in brief

Written by CannIntelligence | 24th July 2019

CBD-Intel brings you regulatory updates and snippets from the US, UK, Italy, Germany and Belgium ...

CBD-Intel business news in brief, 15th-19th July 2019

Written by CannIntelligence | 22nd July 2019

Christian Books or hemp extract? CBD-Intel brings you a pot-pourri of CBD-related news snippets from around the business world ...

Mainstream US drugstore chains announce plans to sell CBD

Written by CannIntelligence | 29th March 2019

CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in...

LATEST ALERTS

Search Results: Curaleaf

Filter by